Ascendis wins US approval for therapy for children with dwarfism

By Sahil Pandey and Puyaan Singh Feb 27 (Reuters) - The U.S. Food and Drug Administration on Friday approved Ascendis Pharma's once-weekly therapy for children with a rare genetic disorder that causes ...

Man put to death for killing a grocery store owner in Florida’s second execution this year

A man convicted of killing a 70-year-old grocery store owner has been put to death in Florida, becoming the second person ...
Healio

FDA approves three new pediatric indications for once-weekly growth hormone injection

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...
BioSpace

New indication in pediatric patients, including term neonates for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) Injection

Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...

FDA approves Novo Nordisk's Sogroya(R) as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
Healthline

Botox Side Effects: Your Guide to Safety and Long-Term Risks

This article provides an overview of Botox safety based on the latest prescribing information (PI) and clinical study data. By understanding both the possible side effects and long-term safety ...
Healthline

Botox: The Cosmetic Use of Botulinum Toxin

Botox Cosmetic is an injectable wrinkle muscle relaxer. It uses botulinum toxin type A, specifically onabotulinumtoxinA, to temporarily paralyze muscle. This reduces the appearance of facial wrinkles.